Morgan Dempsey Capital Management LLC held its position in Teleflex Inc. (NYSE:TFX) during the second quarter, Holdings Channel reports. The fund owned 965 shares of the medical technology company’s stock at the end of the second quarter. Morgan Dempsey Capital Management LLC’s holdings in Teleflex were worth $171,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Huntington National Bank increased its position in Teleflex by 6.5% in the second quarter. Huntington National Bank now owns 820 shares of the medical technology company’s stock valued at $145,000 after buying an additional 50 shares during the last quarter. Rice Hall James & Associates LLC increased its position in Teleflex by 0.6% in the second quarter. Rice Hall James & Associates LLC now owns 75,130 shares of the medical technology company’s stock valued at $13,321,000 after buying an additional 411 shares during the last quarter. Capital Fund Management S.A. bought a new position in Teleflex during the second quarter valued at about $227,000. Retirement Systems of Alabama increased its position in Teleflex by 4.8% in the second quarter. Retirement Systems of Alabama now owns 56,234 shares of the medical technology company’s stock valued at $9,971,000 after buying an additional 2,565 shares during the last quarter. Finally, Louisiana State Employees Retirement System increased its position in Teleflex by 0.9% in the second quarter. Louisiana State Employees Retirement System now owns 11,600 shares of the medical technology company’s stock valued at $2,057,000 after buying an additional 100 shares during the last quarter. 93.77% of the stock is owned by hedge funds and other institutional investors.
Shares of Teleflex Inc. (NYSE:TFX) traded down 0.73% during mid-day trading on Friday, reaching $167.83. 236,629 shares of the company’s stock traded hands. The stock has a market cap of $7.39 billion, a PE ratio of 29.79 and a beta of 0.83. Teleflex Inc. has a 12 month low of $123.79 and a 12 month high of $188.79. The firm has a 50 day moving average price of $177.32 and a 200-day moving average price of $170.06.
Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, July 28th. The medical technology company reported $1.89 EPS for the quarter, beating analysts’ consensus estimates of $1.74 by $0.15. The firm earned $473.60 million during the quarter, compared to analysts’ expectations of $468.40 million. Teleflex had a net margin of 14.89% and a return on equity of 15.59%. The company’s revenue for the quarter was up 4.8% compared to the same quarter last year. During the same quarter last year, the company posted $1.42 earnings per share. On average, analysts predict that Teleflex Inc. will post $7.33 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Thursday, September 15th. Stockholders of record on Monday, August 15th were paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date of this dividend was Thursday, August 11th. Teleflex’s dividend payout ratio is presently 24.11%.
TFX has been the topic of several research reports. Barclays PLC restated an “overweight” rating and set a $183.00 price objective (up previously from $170.00) on shares of Teleflex in a report on Tuesday, June 14th. Zacks Investment Research upgraded shares of Teleflex from a “hold” rating to a “buy” rating and set a $192.00 price objective on the stock in a report on Wednesday, June 29th. Leerink Swann boosted their price objective on shares of Teleflex from $183.00 to $190.00 and gave the stock a “market perform” rating in a report on Friday, July 29th. Finally, Jefferies Group boosted their price objective on shares of Teleflex from $157.00 to $185.00 and gave the stock a “hold” rating in a report on Friday, July 29th. Two analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. Teleflex presently has a consensus rating of “Buy” and an average target price of $171.33.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company markets and sells its products to hospitals and healthcare providers, across the world, through a combination of its direct sales force and distributors.
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Inc. (NYSE:TFX).
Receive News & Ratings for Teleflex Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Inc. and related companies with MarketBeat.com's FREE daily email newsletter.